Serum α-fetoprotein level as a biomarker for early recurrence after R0 resection in primary hepatocellular carcinoma
ObjectivesTo investigate the impact of serum α-fetoprotein (AFP) levels on survival and early recurrence after R0 resection in primary hepatocellular carcinoma (HCC).MethodsWe retrospectively analyzed clinical data of 582 patients with primary HCC (male: 488, female: 94; mean age: 51 years [age rang...
Gespeichert in:
Veröffentlicht in: | Family Medicine and Community Health 2013-06, Vol.1 (2), p.9-14 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | ObjectivesTo investigate the impact of serum α-fetoprotein (AFP) levels on survival and early recurrence after R0 resection in primary hepatocellular carcinoma (HCC).MethodsWe retrospectively analyzed clinical data of 582 patients with primary HCC (male: 488, female: 94; mean age: 51 years [age range, 31-73 years]) who underwent R0 resection between January 1997 and December 2009. The 1-, 3-, and 5-year overall survival (OS) rates and the clinico-pathological factors between the AFP-negative and AFP-positive groups were compared. Risk factors of early recurrence in the AFP-positive group were further analyzed.ResultsAge and histological differentiation were significantly lower in the AFP-positive group than in AFP-negative group (χ2=1 1.004, 32.293; P=0.000). In the AFP-positive group, serum γ-glutamyl transferase levels, tumor diameters, TNM stage, and early recurrence rate were higher (χ2=9.814 to 14.009, P |
---|---|
ISSN: | 2305-6983 2009-8774 |
DOI: | 10.15212/FMCH.2013.0202 |